Biofrontera Inc. (NASDAQ: BFRI)
$1.0100
-0.0100 ( +3.06% ) 95.4K
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Market Data
Open
$1.0100
Previous close
$1.0200
Volume
95.4K
Market cap
$7.68M
Day range
$0.9630 - $1.0500
52 week range
$0.6100 - $3.9000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 03, 2024 |
8-k | 8K-related | 16 | Apr 30, 2024 |
8-k | 8K-related | 14 | Apr 25, 2024 |
def | Proxies and info statements | 7 | Apr 17, 2024 |
8-k/a | 8K-related | 14 | Apr 03, 2024 |
8-k | 8K-related | 15 | Mar 26, 2024 |
def | Proxies and info statements | 6 | Mar 21, 2024 |
8-k | 8K-related | 16 | Mar 15, 2024 |
10-k | Annual reports | 122 | Mar 15, 2024 |
pre | Proxies and info statements | 6 | Mar 08, 2024 |